ISRCTN ISRCTN97731480
DOI https://doi.org/10.1186/ISRCTN97731480
Protocol serial number MCT-65009
Sponsor University Hospital of Montreal (CHUM) (Canada)
Funder Canadian Institutes of Health Research (CIHR) (Canada) - http://www.cihr-irsc.gc.ca (ref: MCT-65009)
Submission date
26/09/2005
Registration date
26/09/2005
Last edited
10/12/2007
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Gilbert Alfred Blaise
Scientific

Hôpital Notre-Dame du CHUM
Laboratoire d'Anesthésie
Porte FS-1136
1560 rue Sherbrooke Est
Montréal
H2L 4M1
Canada

Phone +1 514-890-8202
Email blaisegil@sympatico.ca

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific title
Study objectivesTo compare two methods of analgesia, optimal perioperative analgesia OPA versus the usual analgesic treatment (UAT), in patients undergoing hand surgery, in terms of postoperative pain control, intensity and duration of the local inflammatory response, impact of pain on function and quality of life.

Trapeziectomy and carpal surgery, bone graph, wrist arthrodesis, distal radial arthrotomy, hand surgery/trauma of hand.
Ethics approval(s)Ethics approval received from the Comité d'éthique de la recherche, CHUM (Centre Hospitalier de l'Université de Montréal) on the 24th March 2003.
Health condition(s) or problem(s) studiedHand surgery
InterventionExperimental group: non-steroidal anti-inflammatory drug (NSAID) 1 hour before surgery, 1 daily after surgery.
Both groups (OPA and UAT) will receive the same treatment until their admission in the recovery room.

Trial details received: 12 September 2005
Intervention typeDrug
PhaseNot Specified
Drug / device / biological / vaccine name(s)Non-Steroidal Anti-Inflammatory Drugs (NSAID)
Primary outcome measure(s)

Reducing pain intensity at rest and during active movements measured at 8 months.

Key secondary outcome measure(s)

1. The impact of pain on Quality of Life (QOL)
2. The impact of pain on activities
3. Inflammation
4. Function

Completion date30/09/2006

Eligibility

Participant type(s)Patient
Age groupAdult
SexAll
Target sample size at registration220
Key inclusion criteriaPatients, either sex, scheduled for trapeziectomy and carpal surgery:
1. Total and partial carpectomy
2. Bone graph
3. Wrist arthrodesis
4. Distal radial arthrotomy
Key exclusion criteria1. Age under 18 years or older than 75 years
2. Pregnant
3. Allergic to morphine, local anesthetics
4. Suffering from other forms of chronic arthritis or other painful conditions treated chronically (every day) with analgesics (i.e. fibromyalagia)
5. Allergic or intolerant to NSAID (COX2 inhibitors)
6. Consuming anticoagulants which cannot be interrupted
7. Suffering from major cardiovascular problems
8. Suffering from cognitive or psychiatric problems, or drug abuse
9. Other recent hand surgery or axillary surgery with sequels
10. Living alone (no help at home)
11. Unable to understand French or English
12. Without phone access or likely to change address during follow-up
Date of first enrolment01/10/2003
Date of final enrolment30/09/2006

Locations

Countries of recruitment

  • Canada

Study participating centre

Hôpital Notre-Dame du CHUM
Montréal
H2L 4M1
Canada

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan